The U.S. Supreme Court ruled Tuesday to reinstate restrictions on the a medication abortion pill that allowed patients to receive it through the mail during the pandemic. The justices ruled 7 to 2 on the decision in favor of the U.S. Federal Drug Administration. The FDA has maintained a rule that a patient must travel to a clinic to pick up the abortion pill mifepristone for the past 20 years when the drug first came onto the market. Reproductive advocates and experts have said that is politically motivated. The patient can take the pill in a place of their own choosing.
The first reproductive rights test for the U.S. Supreme Court since Justice Ruth Bader Ginsburg’s death will likely be the court battle over whether people should be able to access the medication mifepristone for abortion through telehealth. The Federal Drug Administration (FDA) requested the U.S. Supreme Court to stay a lower court’s decision to enable women to receive mifepristone through telehealth during the pandemic. Prior to the pandemic, people had to travel—in some cases hundreds of miles—to a clinic to receive the medication. But, patients do not have to take the medication at the clinic. They can return home to take it in the privacy of their homes.
The American College of Obstetricians and Gynecologists (ACOG) and other partners sought—and received—a preliminary injunction this summer from a Maryland judge barring the FDA from enforcing its in-person requirement to receive mifepristone.
Martin Heinrich was one of 13 Democratic U.S. senators who voted against legislation earlier this week that would have allowed Americans to buy prescription drugs from other countries. The measure, a health care reform idea often supported by progressives, came as an amendment to legislation aimed at changing Senate rules to allow majority votes on budget bills. The procedural changes, which the Senate narrowly approved in the early hours of Thursday, are the first step in Republican plans to repeal as much of the Affordable Care Act, known as Obamacare, as they can. Bernie Sanders, the Vermont independent senator who unsuccessfully ran for the Democratic Party presidential nomination last year, sponsored the amendment with Sen. Amy Klobuchar, D-Minnesota. Senators rejected the amendment on a 52-48 margin, with 12 Republicans casting their votes in favor.